SS Innovations Appoints Naveen Kumar Amar as CFO

By Tamara Parker • Friday, September 26 10:20 • Permanent Link

SS Innovations International, Inc. (NASDAQ: SSII) has appointed Naveen Kumar Amar as its Chief Financial Officer, effective September 24, 2025. This new appointment follows Dr. Vishwa Srivastava's service as the interim Chief Financial Officer since July 2025. Dr. Vishwa Srivastava will continue in his role as the company’s Chief Executive Officer – Asia Pacific.

Naveen Kumar Amar brings over 25 years of global finance leadership experience to SS Innovations. He has expertise in financial accounting and reporting, planning and analysis, budgeting, forecasting, corporate finance, treasury operations, governance, internal controls, and both U.S. and Indian GAAP. He has been recognized as one of India’s top financial executives by various publications and organizations, including Forbes India Magazine, Forbes Asia Magazine, CFO India Forum, and Chartered Institute of Management Accountants, London.

Most recently, Mr. Amar has provided virtual CFO services to clients based in the United States, Canada, and the United Kingdom. Among his previous positions, he served as Head of Finance & Commercial for SpiceXpress, the cargo division of SpiceJet; Global CFO for Munch Ado India Private Ltd., a software enterprise technology provider; Senior Vice President – Finance & Compliance and Company Secretary for MSD Wellcome Trust Hilleman Laboratories Private Ltd., a global vaccine manufacturer; Chief Financial Officer – India & Australia and Company Secretary for eDirect Proprietary Ltd., a telecommunications provider; and India Manager – Financial Consolidation and Company Secretary for GE India.

Mr. Amar graduated with a Bachelor of Commerce degree from the University of Delhi and received a Post Graduate Diploma in Business Management from All India Management Association’s Centre of Management Education. In addition, he earned the Chartered Accountant designation from the Institute of Chartered Accountants of India as well as the Company Secretary designation from the Institute of Company Secretaries of India.

SS Innovations International, Inc. develops innovative surgical robotic technologies aimed at making the benefits of robotic surgery affordable and accessible to a larger segment of the global population. Its product range includes its proprietary “SSI Mantra” surgical robotic system and its comprehensive suite of “SSI Mudra” surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. The company, headquartered in India, plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Following these announcements, the company's shares moved -3.25%, and are now trading at a price of $5.65. For the full picture, make sure to review SS Innovations International's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.